Overview
Hyojin Lee practices practicing medicine in Ottawa, Canada.
Their clinical expertise encompasses Maturity Onset Diabetes of the Young, Neurotoxicity Syndromes, and Type 2 Diabetes (T2D).
They are actively involved in clinical research, co-authoring 15 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hyojin Lee
Is Hyojin Lee a top-rated expert for Maturity Onset Diabetes of the Young?
MediFind is an objective health platform that identifies experts based on real-world data. Hyojin Lee is classified as an Experienced expert for Maturity Onset Diabetes of the Young, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hyojin Lee participate in research or clinical trials?
Yes. Hyojin Lee has published 15 articles and abstracts on conditions like Maturity Onset Diabetes of the Young. You can view a list of Hyojin Lee's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Maturity Onset Diabetes of the Young
- Neurotoxicity SyndromesLee isExperienced. Learn about Neurotoxicity Syndromes.
- Type 2 Diabetes (T2D)Lee isExperienced. Learn about Type 2 Diabetes (T2D).